A detailed history of Coastline Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Coastline Trust CO holds 40 shares of BIIB stock, worth $6,298. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Holding current value
$6,298
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$189.07 - $236.8 $7,562 - $9,472
40 New
40 $7,000
Q4 2018

Jan 15, 2019

SELL
$278.5 - $352.75 $159,580 - $202,125
-573 Closed
0 $0
Q3 2018

Oct 17, 2018

BUY
$293.51 - $383.83 $168,181 - $219,934
573 New
573 $202,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Coastline Trust CO Portfolio

Follow Coastline Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastline Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Coastline Trust CO with notifications on news.